Health in Cote d'Ivoire 1,376 indicators covering health for Cote d'Ivoire. IndicatorLatest Year10-yr change Rank Neonatal mortality rate - Remains constant 27.4 2030 unchanged 17th Neonatal mortality rate - Current trends maintained 24.59 2030 down 8.6% 17th Neonatal mortality rate - High-income country average rate matched 2.8 2030 down 85.1% 1st Neonatal mortality rate - SDG target met 12 2030 down 49.7% 1st Under 5 mortality rate - Remains constant 64.47 2030 unchanged 18th Under 5 mortality rate - Current trends maintained 53.69 2030 down 14.1% 18th Under 5 mortality rate - High-income country average rate matched 5.09 2030 down 87.9% 1st Under 5 mortality rate - SDG target met 25 2030 down 54.4% 1st Mortality rate age 10-19 - Remains constant 13.74 2030 up 1.7% 23rd Mortality rate age 10-19 - Current trends maintained 11.43 2030 down 12.8% 24th Mortality rate age 10-19 - High-income country average rate matched 5.33 2030 down 35.6% 40th Neonatal deaths - Remains constant 29,793 2030 up 6.9% 18th Neonatal deaths - Current trends maintained 26,733 2030 down 2.3% 18th Neonatal deaths - SDG target met 13,050 2030 down 46.3% 23rd Under-five deaths - Remains constant 68,491 2030 up 6.3% 18th Under-five deaths - Current trends maintained 57,045 2030 down 8.7% 19th Under-five deaths - SDG target met 26,666 2030 down 51.3% 22nd Deaths age 10 to 19 - Remains constant 11,564 2030 up 11.6% 24th Deaths age 10 to 19 - Current trends maintained 9,869 2030 down 2.2% 26th Mortality caused by road traffic injury 24.1 per 100,000 population 2019 down 5.5% 50th Mortality caused by road traffic injury, female 14.6 per 100,000 female population 2019 down 2.0% 37th Mortality caused by road traffic injury, male 33.4 per 100,000 male population 2019 down 6.7% 58th Ipv vaccine coverage 81 2024 up 326.3% 150th Deaths in armed conflicts by country, annual growth rate -100 % change on previous year 2017 unchanged 33rd Deaths in armed conflicts by region, annual growth rate -100 % change on previous year 2017 unchanged 33rd Proportion of health care facilities with limited water services 52.91 2025 unchanged 3rd Tb patients living with hiv receiving art 2,632 2021 up 52.6% 23rd HIV-positive TB patients on ART (antiretroviral therapy) 94.0% 2024 up 25.3% 80th Treatment success rate for patients treated for MDR-TB 75.0% 2022 down 11.8% 70th New leprosy case detection rate per 1 000 000 population 18.29 2024 down 58.2% 32nd Treatment success rate: HIV-positive TB cases 82 2023 up 18.8% 47th Prevalence of wasting, weight for height 8.1% 2021 up 52.8% 20th Estimated number of children (aged 0-17 years) who have lost one or 1.66 million 2024 up 9.9% 14th Weight-for-height <-2 SD 8.06 2021 up 51.6% 20th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 70.0% 2025 — 129th International Health Regulations core capacity scores, SPAR version 20 2025 — 162nd Prevalence of underweight, weight for age 13.6% 2021 down 12.3% 35th Leprosy registered prevalence rate per 1 000 000 population 17.16 2024 down 49.6% 38th Leprosy - Number of new leprosy cases among children 47 2024 down 37.3% 17th Leprosy - Number of cases registered for treatment 548 2024 down 22.7% 23rd New leprosy child case detection rate (less than 15 years of age) per 3.6 2024 down 53.3% 27th Children (0-14) living with HIV 17,000 2024 down 60.5% 14th Ipv1 number unvaccinated 157,903 2023 down 77.6% 26th Children living with hiv 17,000 2024 down 60.5% 14th Contraceptive prevalence, any method 32.0% 2022 up 75.7% 92nd Children (ages 0-14) newly infected with HIV 1,000 2024 down 65.5% 22nd Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Number of children newly infected with hiv 1,000 2024 down 65.5% 22nd Share of children under fifteen years old with hiv 1,025 2024 down 64.2% 23rd Number of female leprosy new cases 242 2024 down 40.5% 19th Estimated number of malaria deaths 10,817 2024 up 13.1% 17th Estimated number of malaria cases 8.56 million 2024 up 43.4% 8th National smoking ban: NUMBER OF PLACES SMOKE-FREE 0 2022 — 157th Contraceptive prevalence, any modern method 25.2% 2022 up 101.2% 90th Number of prevalent tuberculosis cases 48,000 2014 down 34.2% 35th Estimated malaria incidence 267.95 2024 up 10.2% 13th Estimated malaria mortality rate 33.87 2024 down 13.1% 25th Number of new G2D leprosy cases 142 2024 down 34.9% 14th Leprosy - New leprosy cases with G2D rate per 1 000 000 population 4.45 2024 down 54.0% 16th 3.7.2 Adolescent birth rate per 1,000 women 119 2017 down 1.1% 16th ← Previous Page 17 of 23 Next →